ADABLIX

This brand name is authorized in Poland.

Active ingredients

The drug ADABLIX contains one active pharmaceutical ingredient (API):

`1`	Bilastine UNII `PA1123N395` - BILASTINE
	Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral Η₁ receptor antagonist affinity and no affinity for muscarinic receptors.
	Read more about Bilastine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R06AX29	Bilastine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX29

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
PL	Rejestru Produktów Leczniczych	100433718

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.